X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10) 10
male (9) 9
index medicus (8) 8
middle aged (8) 8
female (7) 7
abridged index medicus (6) 6
aged (6) 6
double-blind method (6) 6
cardiac & cardiovascular systems (4) 4
heart failure (4) 4
medicine, general & internal (4) 4
mortality (4) 4
stroke (4) 4
treatment outcome (4) 4
cardiovascular (3) 3
diagnosis (3) 3
drug therapy (3) 3
heart attacks (3) 3
myocardial-infarction (3) 3
patients (3) 3
physiological aspects (3) 3
acute coronary syndrome (2) 2
acute coronary syndrome - complications (2) 2
acute coronary syndrome - drug therapy (2) 2
acute coronary syndromes (2) 2
adenosine monophosphate - adverse effects (2) 2
adenosine monophosphate - analogs & derivatives (2) 2
adult (2) 2
angioplasty, balloon, coronary - methods (2) 2
antiplatelet therapy (2) 2
association (2) 2
bleeding (2) 2
cardiac and cardiovascular systems (2) 2
cardiac patients (2) 2
cardiology (2) 2
care and treatment (2) 2
clinical medicine (2) 2
clinical trials (2) 2
clopidogrel (2) 2
coronary artery disease (2) 2
dosage and administration (2) 2
drug dosages (2) 2
drug therapy, combination (2) 2
fees & charges (2) 2
follow-up studies (2) 2
health risk assessment (2) 2
hemorrhage - chemically induced (2) 2
hospitalization (2) 2
infusions, intravenous (2) 2
internal medicine (2) 2
ischemia (2) 2
kardiologi (2) 2
klinisk medicin (2) 2
management (2) 2
medical and health sciences (2) 2
medicin och hälsovetenskap (2) 2
milrinone (2) 2
myocardial infarction (2) 2
outcomes (2) 2
pcsk9 (2) 2
prevention (2) 2
prospective studies (2) 2
research (2) 2
risk (2) 2
thrombosis (2) 2
ticlopidine - adverse effects (2) 2
ticlopidine - analogs & derivatives (2) 2
transluminal angioplasty (2) 2
urea - administration & dosage (2) 2
urea - analogs & derivatives (2) 2
veins & arteries (2) 2
[sdv.mhep.csc]life sciences [q-bio]/human health and pathology/cardiology and cardiovascular system (1) 1
[sdv.mhep]life sciences [q-bio]/human health and pathology (1) 1
[sdv]life sciences [q-bio] (1) 1
acetates - adverse effects (1) 1
acetates - therapeutic use (1) 1
acetates; acute coronary syndrome; aged; angina, unstable; atherosclerosis; atorvastatin calcium; double-blind method; early termination of clinical trials; female; heptanoic acids; humans; indoles; male; middle aged; phospholipases a; phospholipases a2, secretory; pyrroles; risk; stroke; survival analysis; treatment outcome; myocardial infarction; medicine (1) 1
acute coronary syndrome - blood (1) 1
adenosine (1) 1
adenosine monophosphate - administration & dosage (1) 1
adenosine monophosphate - antagonists & inhibitors (1) 1
adenosine monophosphate - pharmacokinetics (1) 1
adenosine monophosphate - therapeutic use (1) 1
adenosine triphosphatase (1) 1
administration, oral (1) 1
aftercare (1) 1
aged, 80 and over (1) 1
aggregation (1) 1
aldosterone (1) 1
aneurysm, false - diagnosis (1) 1
aneurysm, false - diagnostic imaging (1) 1
aneurysms (1) 1
angina (1) 1
angina pectoris (1) 1
angina pectoris - diagnosis (1) 1
angina pectoris - drug therapy (1) 1
angina pectoris - physiopathology (1) 1
angina, unstable (1) 1
anti-inflammatory drugs (1) 1
antibodies, monoclonal - adverse effects (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9792, pp. 676 - 683
Journal Article
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 2, pp. 176 - 185
Abstract Background Cangrelor, an intravenous, reversible P2Y12 antagonist, is approved for use in patients undergoing percutaneous coronary intervention... 
Cardiovascular | Internal Medicine | coronary artery disease | bleeding | antiplatelet therapy | outcomes | CARDIAC & CARDIOVASCULAR SYSTEMS | PRIMARY PCI | BIVALIRUDIN | IMPAIRED BIOAVAILABILITY | CHAMPION PHOENIX | CLOPIDOGREL | PLATELET INHIBITION | BLOOD-TRANSFUSION | ELEVATION MYOCARDIAL-INFARCTION | INSIGHTS | Prospective Studies | Ticlopidine - therapeutic use | Humans | Middle Aged | Male | Aspirin - adverse effects | Ticlopidine - adverse effects | Female | Aspirin - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Double-Blind Method | Angioplasty, Balloon, Coronary - methods | Myocardial Ischemia - prevention & control | Treatment Outcome | Adenosine Monophosphate - therapeutic use | Ticlopidine - analogs & derivatives | Adenosine Monophosphate - adverse effects | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Adenosine Monophosphate - analogs & derivatives | Clopidogrel | Aged | Hemorrhage - chemically induced | Infusions, Intravenous | Cohort Studies | Transluminal angioplasty | Continuing medical education | Cardiac patients | Medical care | Research institutes | Cardiology | Quality management | Heart attacks | Mortality | Thrombosis | Patients | Studies | Consortia | Ischemia | Coronary vessels | Bailouts | Intubation | Acute coronary syndromes | Stents | Drug dosages | Veins & arteries
Journal Article
by Ray, Kausik K and Ray, Michael and Colhoun, Helen M and Szarek, Michael and Baccara-Dinet, Marie and Bhatt, Deepak L and Bittner, Vera A and Budaj, Andrzej J and Budaj, Andrzej and Diaz, Rafael and Diaz, Ariel and Goodman, Shaun G and Hanotin, Corinne and Harrington, Robert A and Jukema, J Wouter and Jukema, J. Wouter and Jukema, Johan and Loizeau, Virginie and Lopes, Renato D and Lopes, Renato and Moryusef, Angèle and Murin, Jan and Pordy, Robert and Ristic, Arsen D and Roe, Matthew T and Tuñón, José and White, Harvey D and White, Matthew and White, Lindsey and Zeiher, Andreas M and Schwartz, Steven and Schwartz, Michael and Schwartz, Gregory G and Steg, Philippe Gabriel and Steg, Ph. Gabriel and Tricoci, Pierluigi and Mahaffey, Kenneth W and Edelberg, Jay M and Lecorps, Guillaume and Sasiela, William J and Tamby, Jean-François and Aylward, Philip E and Drexel, Heinz and Sinnaeve, Peter and Dilic, Mirza and Gotcheva, Nina N and Prieto, Juan-Carlos and Prieto, Juan C and Yong, Huo and López-Jaramillo, Patricio and Pećin, Ivan and Reiner, Zeljko and Ostadal, Petr and Viigimaa, Margus and Nieminen, Markku S and Chumburidze, Vakhtang and Marx, Roger and Marx, Nikolaus and Danchin, Nicolas and Liberopoulos, Evangelos and Montenegro Valdovinos, Pablo Carlos and Tse, Hung-Fat and Kiss, Robert Gabor and Xavier, Denis and Zahger, Doron and Valgimigli, Marco and Kimura, Kazuo and Kimura, Takeshi and Kim, Sang-Hyun and Kim, Youngkwon and Kim, Chongjin and Kim, Hyo Soo and Kim, Hack-Lyoung and Kim, Moo Hyun and Kim, Hyo-Soo and Kim, Hae Young and Erglis, Andrejs and Laucevicius, Aleksandras and Kedev, Sasko and Yusoff, Khalid and Ramos López, Gabriel Arturo and Alings, Marco and Halvorsen, Sigrun and Correa Flores, Roger M and Morais, Joao and Dorobantu, Maria and Karpov, Yuri and Karpov, Yuriy and Chua, Terrance and Fras, Zlatko and Dalby, Anthony J and de Silva, H. Asita and Hagström, Emil and Landmesser, Ulf and Chiang, Chern-En and Sritara, Piyamitr and Guneri, Sema and Parkhomenko, Alexander and Moriarty, Patrick M and Moriarty, Katie and ... and ODYSSEY OUTCOMES Comm Investigato and ODYSSEY OUTCOMES Committees and Investigators and Medicinska fakulteten and Medicinska och farmaceutiska vetenskapsområdet and Kardiologi and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Uppsala universitet and Institutionen för medicinska vetenskaper and Uppsala kliniska forskningscentrum (UCR)
The Lancet Diabetes & Endocrinology, ISSN 2213-8587, 08/2019, Volume 7, Issue 8, pp. 618 - 628
After acute coronary syndrome, diabetes conveys an excess risk of ischaemic cardiovascular events. A reduction in mean LDL cholesterol to 1·4–1·8 mmol/L with... 
MYOCARDIAL-INFARCTION | LIRAGLUTIDE | STATIN THERAPY | BLOOD-GLUCOSE | GUIDELINES | ENDOCRINOLOGY & METABOLISM | RISK | PCSK9 | GENETIC-VARIANTS | ASSOCIATION | EVOLOCUMAB | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Endokrinologi och diabetes | Medicin och hälsovetenskap | Klinisk medicin | Endocrinology and Diabetes
Journal Article
Journal of Thrombosis and Thrombolysis, ISSN 0929-5305, 7/2012, Volume 34, Issue 1, pp. 44 - 55
Journal Article